INCLISIRAN for Hyperlipidaemia: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 516 adverse event reports in the FDA FAERS database where INCLISIRAN was used for Hyperlipidaemia.
Most Reported Side Effects for INCLISIRAN
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Arthralgia | 689 | 10.8% | 2 | 23 |
| Myalgia | 518 | 8.1% | 0 | 14 |
| Injection site pain | 488 | 7.7% | 0 | 20 |
| Low density lipoprotein increased | 423 | 6.7% | 3 | 5 |
| Pain in extremity | 417 | 6.6% | 0 | 34 |
| Pain | 342 | 5.4% | 1 | 27 |
| Fatigue | 325 | 5.1% | 3 | 26 |
| Drug ineffective | 318 | 5.0% | 1 | 17 |
| Diarrhoea | 309 | 4.9% | 1 | 29 |
| Dyspnoea | 297 | 4.7% | 10 | 52 |
| Headache | 234 | 3.7% | 2 | 19 |
| Rash | 207 | 3.3% | 0 | 10 |
| Product storage error | 204 | 3.2% | 0 | 0 |
| Muscle spasms | 202 | 3.2% | 0 | 16 |
| Injection site reaction | 179 | 2.8% | 0 | 2 |
Other Indications for INCLISIRAN
Product used for unknown indication (3,669)
Arteriosclerosis (539)
Hypercholesterolaemia (486)
Low density lipoprotein increased (392)
Type iia hyperlipidaemia (313)
Blood cholesterol increased (161)
Low density lipoprotein decreased (106)
Low density lipoprotein (103)
Dyslipidaemia (94)
Coronary artery disease (60)
Other Drugs Used for Hyperlipidaemia
EVOLOCUMAB (10,208)
ATORVASTATIN (3,648)
ALIROCUMAB (3,317)
ROSUVASTATIN (1,591)
SIMVASTATIN (1,320)
EZETIMIBE (796)
FENOFIBRATE (472)
PRAVASTATIN (311)
COLESEVELAM (251)
PITAVASTATIN (199)